IMMU - Immunomedics Inc. patents

This listing is of recent patents (patent applications) which may be related to Immunomedics Inc. according to a patent app search. In *most* cases, they are listed under Immunomedics Inc. because the company is listed in the Agent field of the patent application. Note: Immunomedics Inc. (IMMU) may have other listings under a different name, spelling or agent. If there is another company with a similar name, it's possible their patents could be inadvertantly included here. Notify us of any issues. Also, FreshPatents.com is not affiliated with Immunomedics Inc., we're just tracking patents related to them as published publically by the USPTO. Full list of Stock Symbols and Company RSS Feeds

SUBSCRIBE to updates on this page: Immunomedics Inc. patents RSS Feed (FREE)

I

IBM
ICAD
IDXX
ILMN
IMA
IMMU
IMN
IN
INFN
INXI
IPAS
IP
IRSN
ISIS
ISRG
ITMN
ITRI
ITW

Symbol	Company	Application #	Date	Title
IMMU	Immunomedics	20120114556	20120510	Immunotherapy of autoimmune disorders using antibodies which target b-cells
IMMU	Immunomedics	20120107235	20120503	Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
IMMU	Immunomedics	20120088299	20120412	Mammalian cell lines for increasing longevity and protein yield from a cell culture
IMMU	Immunomedics	20120082617	20120405	Immunoconjugates with an intracellularly-cleavable linkage
IMMU	Immunomedics	20120076727	20120329	In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
IMMU	Immunomedics	20120063993	20120315	Therapeutic and diagnostic conjugates for use with multispecific antibodies
IMMU	Immunomedics	20120040431	20120216	Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
IMMU	Immunomedics	20120039797	20120216	Antibody therapy
IMMU	Immunomedics	20120034185	20120209	Anti-cd20 antibodies and fusion proteins therof and methods of use
IMMU	Immunomedics	20110311531	20111222	Immunotherapy of autoimmune disorders using antibodies which target b-cells
IMMU	Immunomedics	20110305631	20111215	Camptothecin conjugates of anti-cd22 antibodies for treatment of b cell diseases
IMMU	Immunomedics	20110300066	20111208	Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
IMMU	Immunomedics	20110293513	20111201	Immunoconjugates with an intracellularly-cleavable linkage
IMMU	Immunomedics	20110286918	20111124	Immunotherapy of autoimmune disorders using antibodies which target b-cells
IMMU	Immunomedics	20110280801	20111117	Methods and compositions for f-18 labeling of proteins, peptides and other molecules
IMMU	Immunomedics	20110274704	20111110	Compositions and methods of use of immunotoxins comprising ranpirnase (rap) show potent cytotoxic activity
IMMU	Immunomedics	20110256053	20111020	Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to b-cell lymphomas and other diseases
IMMU	Immunomedics	20110243841	20111006	Antibody-based depletion of antigen-presenting cells and dendritic cells
IMMU	Immunomedics	20110244546	20111006	Internalizing anti-cd74 antibodies and methods of use
IMMU	Immunomedics	20110236404	20110929	Methods for protein expression in mammalian cells in serum-free medium
IMMU	Immunomedics	20110236304	20110929	Structural variants of antibodies for improved therapeutic characteristics
IMMU	Immunomedics	20110229407	20110922	Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
IMMU	Immunomedics	20110223645	20110915	Multivalent carriers of bi-specific antibodies
IMMU	Immunomedics	20110195023	20110811	Internalizing anti-cd74 antibodies and methods of use
IMMU	Immunomedics	20110189268	20110804	Inhibition of placenta growth factor (plgf) mediated metastasis and/or angiogenesis
IMMU	Immunomedics	20110189085	20110804	Antibody therapy
IMMU	Immunomedics	20110171126	20110714	Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma
IMMU	Immunomedics	20110165073	20110707	Immunotherapy of b-cell malignancies using anti-cd22 antibodies
IMMU	Immunomedics	20110165072	20110707	Detection of early-stage pancreatic adenocarcinoma
IMMU	Immunomedics	20110117105	20110519	Method of treating immune disease using b-cell antibodies
IMMU	Immunomedics	20110117010	20110519	Methods and compositions for administering therapeutic and diagnostic agents
IMMU	Immunomedics	20110110854	20110512	Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
IMMU	Immunomedics	20110076233	20110331	Delivery system for cytotoxic drugs by bispecific antibody pretargeting
IMMU	Immunomedics	20110070155	20110324	Anti-cd74 immunoconjugates and methods
IMMU	Immunomedics	20110070156	20110324	Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
IMMU	Immunomedics	20110064653	20110317	Class i anti-cea antibodies and uses thereof
IMMU	Immunomedics	20110052489	20110303	Anti-cd19 antibodies
IMMU	Immunomedics	20110020273	20110127	Bispecific immunocytokine dock-and-lock (dnl) complexes and therapeutic use thereof
IMMU	Immunomedics	20110008251	20110113	Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
IMMU	Immunomedics	20100311162	20101209	Mammalian cell lines for increasing longevity and protein yield from a cell culture
IMMU	Immunomedics	20100284906	20101111	Internalizing anti-cd74 antibodies and methods of use
IMMU	Immunomedics	20100272636	20101028	Anti-cd74 immunoconjugates and methods of use
IMMU	Immunomedics	20100266496	20101021	Anti-cd74 immunoconjugates and methods of use
IMMU	Immunomedics	20100266497	20101021	Internalizing anti-cd74 antibodies and methods of use
IMMU	Immunomedics	20100261885	20101014	Pegylation by the dock and lock (dnl) technique
IMMU	Immunomedics	20100233779	20100916	Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
IMMU	Immunomedics	20100226884	20100909	Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r)
IMMU	Immunomedics	20100221175	20100902	Antibody therapy
IMMU	Immunomedics	20100221210	20100902	Dimeric alpha interferon pegylated site-specifically shows enhanced and prolonged efficacy in vivo
IMMU	Immunomedics	20100221177	20100902	Rs7 antibodies
IMMU	Immunomedics	20100216662	20100826	Inhibition of placenta growth factor (plgf) mediated metastasis and/or angiogenesis
IMMU	Immunomedics	20100202961	20100812	D-amino acid peptides
IMMU	Immunomedics	20100196989	20100805	Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
IMMU	Immunomedics	20100196267	20100805	Humanized l243 antibodies
IMMU	Immunomedics	20100196266	20100805	Humanized anti-hla-dr antibodies
IMMU	Immunomedics	20100189689	20100729	Tetrameric cytokines with improved biological activity
IMMU	Immunomedics	20100189641	20100729	Novel strategies for improved cancer vaccines
IMMU	Immunomedics	20100158802	20100624	Chimeric, human and humanized anti-csap monoclonal antibodies
IMMU	Immunomedics	20100158803	20100624	Production and use of novel peptide-based agents for use with bi-specific antibodies
IMMU	Immunomedics	20100136626	20100603	Production and use of novel peptide-based agents for use with bi-specific antibodies
IMMU	Immunomedics	20100104589	20100429	Immunoconjugates with an intracellularly-cleavable linkage
IMMU	Immunomedics	20100074840	20100325	Anthracycline-antibody conjugates for cancer therapy
IMMU	Immunomedics	20100068137	20100318	Dock-and-lock (dnl) vaccines for cancer therapy
IMMU	Immunomedics	20100068136	20100318	Anti-cd19 antibodies
IMMU	Immunomedics	20100015046	20100121	Camptothecin-binding moiety conjugates
IMMU	Immunomedics	20100015048	20100121	Internalizing anti-cd74 antibodies and methods of use
IMMU	Immunomedics	20100008855	20100114	Production and use of novel peptide-based agents with bispecific antibodies
IMMU	Immunomedics	20100008858	20100114	Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules

###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Immunomedics Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Immunomedics Inc. with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###